Bidimensional Immunoelectrophoresis Abnormal Migration of Serum Antithrombin III in Coumarin-Treated Patients

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1981; 46(03): 669
DOI: 10.1055/s-0038-1653447

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Antonio Girolami

Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
Giovanni M Patrassi

Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
Giovanna Cappellato

Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
Vittorio Pengo

Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy

Received 27 April 1981

Accepted 09 August 1981

Publication Date:
05 July 2018 (online)

References
1 Kaula Evon, Kaula KN von. Antithrombin III and disease. Am J Clin Path 1967; 48: 69-80

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Marciniak E, Farley CH, De Simone PhA. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219-231

Reference Link Ris
PubMed Search in Google Scholar
3 Bull H, Mackie I, Brozovic M, Woodings D. Antithrombin III in patients on long-term oral anticoagulants. J Clin Pathol 1980; 33: 1202-1205

Reference Link Ris
Crossref PubMed Search in Google Scholar
4 Girolami A, Pengo V, Patrassi GM, Cappellato G, Vianello C, Cartei L. Antithrombin III Padua: a “new” congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease (in preparation).

Reference Link Ris
PubMed